Jennison Associates
INFI

Jennison Associates’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Jennison Associates’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-372,744
Closed -$6.5M – 742
2013
Q3 		$6.5M Sell
372,744
-2,349
-0.6% -$45K 0.01% 494
2013
Q2 		$6.09M Buy
+375,093
New +$11.6M 0.01% 482

Other funds holding INFI

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Jennison Associates's INFI Position: Q4 2013 in Review

Jennison Associates sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2013, closing a stake of 372,744 shares — an estimated $6.5M sold.

Jennison Associates first reported a position in INFI in Q2 2013 and held it in 2 quarters. The position peaked at $6.5M in Q3 2013. 104 funds tracked by Wall St. Rank hold INFI as of Q4 2013.

  • Jennison Associates reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Jennison Associates sold 372,744 Infinity Pharmaceuticals, Inc. shares in Q4 2013, an estimated $6.5M.
  • Jennison Associates first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
  • Jennison Associates's Infinity Pharmaceuticals, Inc. position peaked at $6.5M in Q3 2013.
  • 104 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2013.

Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.